Arthritis Research & Therapy

official impact factor 4.36

Open Access

Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis

Lisa Carroll, Ian H Frazer, Malcolm Turner, Thomas H Marwick and Ranjeny Thomas*

Arthritis Research & Therapy 2007, 9:R39 doi:10.1186/ar2175

Accesses  

  • Last 30 days: 54 accesses
  • Last 365 days: 534 accesses
  • All time: 3857 accesses